What would you like to look for?
Site search
8 September 2023

Epiterna SA ("Epiterna"), a Swiss longevity company founded in 2022 by Alejandro Ocampo and Kevin Perez as a spin-off from Alejandro Ocampo's laboratory at the University of Lausanne, has raised EUR 10 million from Prima Materia, an investment firm founded by Spotify founder Daniel Ek and investor and early Spotify backer Shakil Khan. The funds will allow Epiterna to fund its growth and accelerate its development.

Epiterna currently develops products that evaluate the impact of medicines on ageing using drugs and compounds that have already been approved to treat specific diseases in humans, dogs, and cats. Epiterna’s innovative high-throughput drug screening platform evaluates medicines that act at the molecular and cellular level in gold-standard animal models of ageing research. The use of small-molecule drugs makes these products more affordable and accessible to a broader audience. By addressing aging as the root cause of disease and physical decline, rather than tackling disease after disease, the company hopes to have a more significant impact on human health and lifespan.

VISCHER advises Epiterna on all legal issues related to the investment and the spin-off from University of Lausanne. The VISCHER team includes Christian Wyss (Partner, Corporate/M&A), Vincent S. Reardon (Managing Associate, Corporate/M&A), Alessandro L. Meyer (Associate, Corporate/M&A), Michael Maurer (Associate, Corporate/M&A), and Oerjan Wickart (Junior Associate, Corporate/M&A).

Press Release: